These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1916648)

  • 21. [The effects of recombinant human growth hormone (r-hGH, SM-9500, genotropin) on growth failure in children with uremia. Japanese Multi-Center Study (Genotropin) Group on Children with Renal Disease].
    Ito K; Kawaguchi H; Shizume K; Hibi I
    Nihon Jinzo Gakkai Shi; 1995 Mar; 37(3):186-93. PubMed ID: 7731107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes with growth hormone treatment in growth hormone deficient children.
    Ocal G; Berberoglu M; Akçurin S; Memioglu N; Ikinciogullari A
    Acta Paediatr Jpn; 1995 Feb; 37(1):7-11. PubMed ID: 7754771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomised study of the effect of two doses of biosynthetic human growth hormone on final height of children with familial short stature.
    Elder CJ; Barton JS; Brook CG; Preece MA; Dattani MT; Hindmarsh PC
    Horm Res; 2008; 70(2):89-92. PubMed ID: 18547955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone treatment in patients with neurosecretory dysfunction.
    Rochiccioli P; Dechaux E; Tauber MT; Pienkowski C; Tiberge M
    Horm Res; 1990; 33 Suppl 4():97-101. PubMed ID: 2245976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone neurosecretory dysfunction. A treatable cause of short stature.
    Spiliotis BE; August GP; Hung W; Sonis W; Mendelson W; Bercu BB
    JAMA; 1984 May; 251(17):2223-30. PubMed ID: 6708271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The safety and effectiveness of human growth hormone using pharmacological dosing.
    Slyper A
    Med Hypotheses; 1995 Dec; 45(6):523-8. PubMed ID: 8771045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biosynthetic human growth hormone: current status and future questions.
    Thompson RG; Conforti P; Holcombe J
    J Endocrinol Invest; 1989; 12(8 Suppl 3):35-9. PubMed ID: 2809097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of growth deceleration after withdrawal of growth hormone therapy in idiopathic short stature.
    Lampit M; Hochberg Z
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3573-7. PubMed ID: 12161476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical Research Council of Canada therapeutic trial of human growth hormone: first 5 years of therapy.
    Guyda H; Friesen H; Bailey JD; Leboeuf G; Beck JC
    Can Med Assoc J; 1975 Jun; 112(11):1301-9. PubMed ID: 165002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human growth hormone therapy of non-growth hormone deficient children.
    Ranke MB
    Pediatrician; 1987; 14(3):178-82. PubMed ID: 3331012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency.
    Zadik Z; Chalew S; Zung A; Landau H; Leiberman E; Koren R; Voet H; Hochberg Z; Kowarski AA
    J Pediatr; 1994 Aug; 125(2):189-95. PubMed ID: 8040760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired GH secretion in patients with SHOX deficiency and efficacy of recombinant human GH therapy.
    Iughetti L; Vannelli S; Street ME; Pirazzoli P; Bertelloni S; Radetti G; Capone L; Stasiowska B; Mazzanti L; Gastaldi R; Maggio MC; Predieri B
    Horm Res Paediatr; 2012; 78(5-6):279-87. PubMed ID: 23208451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Turner's syndrome with methionyl human growth hormone for six months.
    Takano K; Hizuka N; Shizume K
    Acta Endocrinol (Copenh); 1986 May; 112(1):130-7. PubMed ID: 3521183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of recombinant growth hormone treatment in children with growth retardation related to long-term glucocorticosteroid therapy.
    Basmaison O; Ranchin B; Zouater H; Robertson A; Gomez R; Koppiker N
    Ann Endocrinol (Paris); 2019 Sep; 80(4):202-210. PubMed ID: 30910221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
    Van Pareren Y; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant DNA produced somatropin in the treatment of prepubertal growth hormone deficient children.
    Chang TC; Kuo HF; Liu PC; Shih KC; Zeisel HJ; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Jan; 47(1):7-12. PubMed ID: 1848467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term treatment of growth hormone insensitivity syndrome with IGF-I. Results of the European Multicentre Study. The Working Group on Growth Hormone Insensitivity Syndromes.
    Ranke MB; Savage MO; Chatelain PG; Preece MA; Rosenfeld RG; Wilton P
    Horm Res; 1999; 51(3):128-34. PubMed ID: 10461018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IGF-I/IGFBP-1 as an index for discrimination between responder and nonresponder to recombinant human growth hormone in malnourished uremic patients on hemodialysis.
    Shinobe M; Sanaka T; Nihei H; Sugino N
    Nephron; 1997; 77(1):29-36. PubMed ID: 9380235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of recombinant human growth hormone for 1 year on body composition and muscle strength in children on long-term steroid therapy: randomized controlled, delayed-start study.
    Simon D; Alberti C; Alison M; Le Henaff L; Chevenne D; Boizeau P; Canal A; Ollivier G; Decostre V; Jacqz-Aigrain E; Carel JC; Czernichow P; Hogrel JY
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2746-54. PubMed ID: 23626006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. French Serono Study Group.
    Rappaport R; Mugnier E; Limoni C; Crosnier H; Czernichow P; Leger J; Limal JM; Rochiccioli P; Soskin S
    J Clin Endocrinol Metab; 1997 Feb; 82(2):452-6. PubMed ID: 9024235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.